|
|
|
|
|
|
|
|
|
|
|
Continuous Processing: Is The Pharma Industry Finally Coming Round To The Idea?
|
|
|
| By
Fedra Pavlou
,
Kevin Nepveux
,
Kris Schoeters
,
Andreas Weiler
,
Shawn Whitfield
|
|
|
|
Industry experts discuss the merits of continuous processing technology and explain why pharma manufacturers should realize the benefits these technologies offer.
|
|
|
|
The Biosimilars Market Today And Tomorrow
|
|
|
| By
Alan Sheppard
|
|
|
|
Last year, the global market for biological products exceeded $125 billion, accounting for 17% of the total market for pharma/biopharma products.
|
|
|
|
A SWOT Analysis Of The Biosimilars Market
|
|
|
| By
Anjan Selz
|
|
|
|
A Strengths, Weaknesses, Opportunities and Threats analysis of the biosimilars market is given.
|
|
|
|
Clinical And Cost Considerations Of Developing A Biosimilar
|
|
|
| By
Keith Watson
,
Cecil Nick
,
Bruce Babbitt
|
|
|
|
Both biosimilar and generic drugs have an abbreviated approval process; however, the clinical trial requirements differ enormously.
|
|
|
|
Launching And Commercializing Biosimilars
|
|
|
| By
Paul Greenland
|
|
|
|
Many hurdles lie between a biosimilar and success on the market. In particular, there are three main questions that companies will be asking themselves.
|
|
|
|
Biosimilars: Perception, cost And The Impact On Biotech Innovation
|
|
|
| By
Ameet Malik
|
|
|
|
In light of the impressive size and predicted growth of the market, there has been a rising interest in the development of biosimilars.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling HPAPIs
|
|
|
| By
Marc Venet
|
|
|
|
The manufacture of high potency active pharmaceutical ingredients (HPAPIs) is on the rise with R&D projects showing a continuing interest in these products.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
News
|
|
|
|
Pharma struggling with social media; Opportunities in the OTC market
|
|
|
|
|
|
|
|
|
Approach social media with caution?
|
|
|
| By
Fedra Pavlou
|
|
|
|
No one can deny the power of social media; it has revolutionised communication and empowered consumers, creating a medium that allows the free flow of information with no authority to control it.
|
|
|
|
